Repare Therapeutics

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities in cancer cells. The company's drugs combine proprietary high-throughput gene editing and target discovery approaches with high-resolution protein crystallography, computational biology, and clinical informatics, enabling patients to improve cancer treatment through single-agent therapies as well as combinations with existing drugs and therapies. Repare Therapeutics aims to become a leading biopharmaceutical company focused on precision oncology and synthetic lethality-based small molecule therapies.